Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Precocious Puberty Therapeutic Management: GnRH Analogs Treatment

  • Chapter
Early Puberty

Abstract

GnRH analog therapy is an effective treatment for central precocious puberty. The therapeutic management of central precocious puberty should be discussed on clinical criteria (rapidly progressive puberty, advance bone age), biological criteria (LH, inhibin B, estradiol), and ultrasound criteria (uterine length, ovarian volume). The optimal timing of treatment discontinuation has not been clearly evaluated. The average age of discontinuation is around 11 years, the physiological age of puberty in girls. Menarche occurs 12–18 months after the end of treatment. Clinical pubertal signs reappear a few months after the end of the treatment. Compromise of adult height, early menarche, and social and behavioral implications is often a concern for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Soriano-Guillen L, Corripio R, Labarta JI et al (2010) Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration. J Clin Endocrinol Metab 95:4305–4313

    Article  CAS  PubMed  Google Scholar 

  2. Teilmann G, Pedersen CB, Jensen TK et al (2005) Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 116:1323–1328

    Article  PubMed  Google Scholar 

  3. Comite F, Cutler GB Jr, Rivier J, Vale WW, Loriaux DL, Crowley WF Jr (1981) Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med 305:1546–1550

    Article  CAS  PubMed  Google Scholar 

  4. Palmert MR, Malin HV, Boepple PA (1999) Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab 84:415–423

    CAS  PubMed  Google Scholar 

  5. Klein KO (1999) Precocious puberty: who has it? Who should be treated? J Clin Endocrinol Metab 84:411–414

    Article  CAS  PubMed  Google Scholar 

  6. Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R (2001) Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height. J Clin Endocrinol Metab 86:4127–4132

    Article  CAS  PubMed  Google Scholar 

  7. Prété G, Couto-Silva AC, Trivin C, Brauner R (2008) Idiopathic central precocious puberty in girls: presentation factors. BMC Pediatr 8:27

    Article  PubMed Central  PubMed  Google Scholar 

  8. Worley G, Houlihan CM, Herman-Giddens ME et al (2002) Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 110:897–902

    Article  PubMed  Google Scholar 

  9. Albanese A, Hopper NW (2007) Suppression of menstruation in adolescents with severe learning disabilities. Arch Dis Child 92:629–632

    Article  PubMed Central  PubMed  Google Scholar 

  10. Resende EA, Lara BH, Reis JD et al (2007) Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab 92:1424–1429

    Article  CAS  PubMed  Google Scholar 

  11. Mogensen SS, Aksglaede L, Mouritsen A et al (2011) Diagnostic work-up of 449 consecutive girls who were referred to be evaluated for precocious puberty. J Clin Endocrinol Metab 96:1393–1401

    Article  CAS  PubMed  Google Scholar 

  12. Neely EK, Wilson DM, Lee PA et al (1995) Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty. J Pediatr 127:47–52

    Article  CAS  PubMed  Google Scholar 

  13. Eckert KL, Wilson DM, Bachrach LK et al (1996) A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty. Pediatrics 97:517–519

    CAS  PubMed  Google Scholar 

  14. Carel JC, Eugster EA, Rogol A et al (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123:752–762

    Article  Google Scholar 

  15. Chalumeau M, Chemaitilly W, Trivin C et al (2002) Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities. Pediatrics 109:61–67

    Article  PubMed  Google Scholar 

  16. Chalumeau M, Hadjiathanasiou CG, Ng SM et al (2003) Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule. J Pediatr 143:445–450

    Article  PubMed  Google Scholar 

  17. Roger M, Lahlou N, Chaussain JL (1996) Gonadotropin-releasing hormone testing in pediatrics. In: Ranke MB (ed) Diagnosis of endocrine function in children and adolescents. Johann Ambrosius Barth Verlag, Heidelberg, pp 346–369

    Google Scholar 

  18. Carel JC, Leger J (2008) Precocious puberty. N Engl J Med 358:2366–2376

    Article  CAS  PubMed  Google Scholar 

  19. Sehested A, Andersson AM, Müller J, Skakkebaek NE (2000) Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists. Horm Res 54:84–91

    Article  CAS  PubMed  Google Scholar 

  20. Hagen CP, Sørensen K, Anderson RA, Juul A (2012) Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist. Fertil Steril 98:1326–1330

    Article  CAS  PubMed  Google Scholar 

  21. Battaglia C, Mancini F, Regnani G et al (2003) Pelvic ultrasound and color Doppler findings in different isosexual precocities. Ultrasound Obstet Gynecol 22:277–283

    Article  CAS  PubMed  Google Scholar 

  22. De Vries L, Horev G, Schwartz M, Philip M (2006) Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche. Eur J Endocrinol 154:891–898

    Article  PubMed  Google Scholar 

  23. Haber HP, Wollmann HA, Ranke MB (1995) Pelvic ultrasonography: early differentiation between isolated premature thelarche and central precocious puberty. Eur J Pediatr 154:182–186

    Article  CAS  PubMed  Google Scholar 

  24. Chemaitilly W, Trivin C, Adan L et al (2001) Central precocious puberty: clinical and laboratory features. Clin Endocrinol (Oxf) 54:289–294

    Article  CAS  Google Scholar 

  25. De Sanctis V, Corrias A, Rizzo V et al (2000) Etiology of central precocious puberty in males: the results of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 13(Suppl 1):687–693

    PubMed  Google Scholar 

  26. Carel JC, Lahlou N, Roger M, Chaussain JL (2004) Precocious puberty and statural growth. Hum Reprod Update 10:135–147

    Article  CAS  PubMed  Google Scholar 

  27. Mul D, Bertelloni S, Carel JC et al (2002) Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results. Horm Res 58:1–7

    Article  CAS  PubMed  Google Scholar 

  28. Bertelloni S, Mul D (2008) Treatment of central precocious puberty by GnRH analogs: long-term outcome in men. Asian J Androl 10:525–534

    Article  CAS  PubMed  Google Scholar 

  29. Klein KO, Barnes KM, Jones JV et al (2001) Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 86:4711–4716

    Article  CAS  PubMed  Google Scholar 

  30. Lazar L, Padoa A, Phillip M (2007) Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity. J Clin Endocrinol Metab 92:3483–3489

    Article  CAS  PubMed  Google Scholar 

  31. Carel JC, Roger M, Ispas S et al (1999) Final height after long-term treatment with triptorelin slow-release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 84:1973–1978

    Article  CAS  PubMed  Google Scholar 

  32. Arrigo T, Cisternino M, Galluzzi F et al (1999) Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 141:140–144

    Article  CAS  PubMed  Google Scholar 

  33. Paul D, Conte FA, Grumbach MM, Kaplan SL (1995) Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 80:546–551

    CAS  PubMed  Google Scholar 

  34. Fuqua JS (2013) Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab 98:2198–2207

    Article  CAS  PubMed  Google Scholar 

  35. Magiakou MA, Manousaki D, Papadaki M et al (2010) The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab 95:109–117

    Article  CAS  PubMed  Google Scholar 

  36. Bouvattier C, Coste J, Rodrigue D et al (1999) Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab 84:3575–3578

    Article  CAS  PubMed  Google Scholar 

  37. Tremblay L, Frigon JY (2005) Precocious puberty in adolescent girls: a biomarker of later psychosocial adjustment problems. Child Psychiatry Hum Dev 36:73–94

    Article  PubMed  Google Scholar 

  38. Copeland W, Shanahan L, Miller S et al (2010) Outcomes of early pubertal timing in young women: a prospective population-based study. Am J Psychiatry 167:1218–1225

    Article  PubMed Central  PubMed  Google Scholar 

  39. Johansson T, Ritzén EM (2005) Very long-term follow-up of girls with early and late menarche. Endocr Dev 8:126–136

    Article  PubMed  Google Scholar 

  40. Lahlou N, Carel JC, Chaussain JL, Roger M (2000) Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab 13(Suppl 1):723–737

    PubMed  Google Scholar 

  41. Carel JC, Lahlou N, Jaramillo O et al (2002) Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg). J Clin Endocrinol Metab 87:4111–4116

    Article  CAS  PubMed  Google Scholar 

  42. Carel JC, Blumberg J, Seymour C et al (2006) Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. Eur J Endocrinol 154:119–124

    Article  CAS  PubMed  Google Scholar 

  43. Neely EK, Hintz RL, Parker B et al (1992) Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr 121:634–640

    Article  CAS  PubMed  Google Scholar 

  44. Mul D, Hughes IA (2008) The use of GnRH agonists in precocious puberty. Eur J Endocrinol 159(Suppl 1):S3–S8

    Article  CAS  PubMed  Google Scholar 

  45. Partsch CJ, Sippell WG (2002) Treatment of central precocious puberty. Best Pract Res Clin Endocrinol Metab 16:165–189

    Article  CAS  PubMed  Google Scholar 

  46. Manasco PK, Pescovitz OH, Blizzard RM (1993) Local reactions to depot leuprolide therapy for central precocious puberty. J Pediatr 123:334–335

    Article  CAS  PubMed  Google Scholar 

  47. Palmert MR, Mansfield MJ, Crowley WF Jr et al (1999) Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab 84:4480–4488

    CAS  PubMed  Google Scholar 

  48. Feuillan PP, Jones JV, Barnes KM et al (2000) Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin- releasing hormone analog therapy. J Clin Endocrinol Metab 85:4036–4038

    Article  CAS  PubMed  Google Scholar 

  49. Seminara S, Nanni L, Generoso M et al (2000) Effect of treatment with cyproterone acetate on uterine bleeding at the beginning of GnRH analogue therapy in girls with idiopathic central precocious puberty. Horm Res Paediatr 73:386–389

    Article  Google Scholar 

  50. Heger S, Müller M, Ranke M et al (2006) Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Mol Cell Endocrinol 25:254–255

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bicêtre hospital and Paris Sud university, Le Kremlin-Bicêtre, France

    Claire Bouvattier

Authors
  1. Claire Bouvattier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claire Bouvattier .

Editor information

Editors and Affiliations

  1. Le Kremlin-Bicêtre, France

    Claire Bouvattier

  2. Toulouse CX 09, France

    Catherine Pienkowski

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bouvattier, C. (2016). Precocious Puberty Therapeutic Management: GnRH Analogs Treatment. In: Bouvattier, C., Pienkowski, C. (eds) Early Puberty. Springer, Paris. https://doi.org/10.1007/978-2-8178-0543-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0543-6_7

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0542-9

  • Online ISBN: 978-2-8178-0543-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation